[1]朱瑞森.131I-MIBG与化疗联合治疗神经母细胞瘤的研究现状[J].国际放射医学核医学杂志,2005,29(2):50-52.
　ZHU Rui-sen.The study status of 131I-MIBG concomitant use with chemotherapy in the theray of neuroblastoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(2):50-52.
点击复制

131I-MIBG与化疗联合治疗神经母细胞瘤的研究现状(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
29
期数:
2005年第2期
页码:
50-52
栏目:
核医学
出版日期:
1900-01-01

文章信息/Info

Title:
The study status of 131I-MIBG concomitant use with chemotherapy in the theray of neuroblastoma
作者:
朱瑞森
200233 上海, 上海交通大学附属第六人民医院核医学科
Author(s):
ZHU Rui-sen
Department of Nuclear Medicine, Shanghai Sixth People’s Hospital, Shanghai Jiao Tong University, Shanghai 200233, China
关键词:
131I-间碘苄胍; 神经母细胞瘤; 化疗
Keywords:
131I-metaiodobenzylguanidine; neuroblastoma; chemotherapy
分类号:
R730.5
摘要:
神经母细胞瘤是一种侵犯儿童、恶性程度高、对射线敏感的肿瘤,近年来主要用131I-间碘苄胍(131I-MIBG)与化疗进行联合治疗,获得了良好的效果。主要综述131I-MIBG与化疗、免疫治疗等联合治疗神经母细胞瘤的几个不同方法和路径,并讨论了联合治疗的机制。
Abstract:
Neuroblastoma,a childhood radiosensitive tumor, is very aggressive and maligment. The combination of 131I-metaiodobenzylguanidine(131I-MIBG) with chemotherapy has resently been employed in the treatment of advanced stage neuroblastoma with encouraging results. In this paper, we reviewed results that several different ways are being assessed of treating neuroblastoma by combining 131I-MIBG with chemotherapy and immumotherapy and discusioned about mechanism of combination therapy.

参考文献/References:

1 Hoefnagel CA. Radionuclide therapy revisited[J]. Eur J Nucl Med,1991, 18(6):408-431.
2 de Kraker J, Hoefnagel CA, Caron H, et al. First line targeted radiotherapy, a new concept in the treatment of advanced stage neuroblastoma[J]. Eur J Cancer, 1995, 31(4):600-602.
3 Mastrangelo R, Tornesello A, Losorella A, et al. Optimal use of the 131I-MIBG and cisplatin combination in advanced neuroblastoma[J].J Neuro Oncol, 1997, 31(1):153-158.
4 Feldman JM, Frankel M, Coleman RE. Platelet uptake thepheochromocytoma-scanning agent 131I-MIBG[J]. Metabolism, 1984, 33(5):397-399.
5 Meller S. Targeted radiotherapy for neuroblastoma[J]. Arch Dis Child,1997, 77(5):389-391.
6 Yanik GA, Levine JE, Matthay KK, et al. Pilot study of 131I-MIBG in combination with myelozblative chemotherapy and autologeus stem-cell support for treatment of neuroblastoma[J]. J Clin Oncol,2002, 20(8):2142-2149.
7 Mastrangelo S, Tornesello A, Diociaiuti L, et al. Treatment of advanced neuroblastoma:feasibility and therapeutic potential of a novel approach combining 131I-MIBG and multiple drug chemotheraoy[J]. BrJ Cancer, 2001, 84(4):460-464.
8 Klingebiel T, Bader P, Bares R, et al. Treatment of neuroblastoma stage 4 with 131I-MIBG, high dose chemotherapy and immuno therapy.A pilot study[J]. EurJ Cancer, 1998, 34(9):1398-1402.
9 Klingebiel T, Berthold F, Treuner J, et al. MIBG in the treatment of 47 patients with neuroblastoma:results of the German Neuroblastoma Trial[J]. Med Pediatr Oncol, 1991, 19(2):84-88.
10 Lashford LS, Lewis IJ, Fielding SL, et al. Phase I/Ⅱ study of iodine 131I-MIBG in Chemoresistant neuroblastoma:a United Kingdom Children’s Cancer Study Group investigation[J]. J Clin Oncol, 1992,10(12):1889-1896.
11 Brodeur GM, Pritchard J, Berthold F, et al. Revision of the international criteria for neuroblastoma diagnosis, staging and response to trestment[J]. J Clin Onco1,1993, 11(8):1466-1477.
12 Montalde PG, Raffaghello L, Guarnaccia F, et al. Increase of MIBG uptake and intracellular half-life during differentiation of human neuroblastoma cells[J]. Int J Cancer, 1996, 67(1):95-100.
13 Armour A, Cunningham SH, Gaze MN, et al. The effect of cisplatin pretreatment on the accumulation of MIBG by neuroblastoma cells in vitro[J]. Br J Cancer, 1997, 75(4):470-476.
14 Klingebiel T, Handgretinger R, Herter M, et al. Peripheral stem cell transplantation in neuroblastoma stage 4 with the use of 131I-MIBG.Prog[J]. Clin Biol Res, 1994, 385:309-317.
15 Voute PA, van de Kleij AJ, de kraker J, et al. Clinical experience with radiation euhancement by hyperbaric oxygen in children with recurrent neuroblastoma stage Ⅳ[J]. Eur J Cancer, 1995, 31A(4):596-600.

相似文献/References:

[1]刘阳,王会祥,周涛.神经母细胞瘤股骨远端干骺端骨转移全身骨显像分析[J].国际放射医学核医学杂志,2012,36(1):27.[doi:10.3760/cma.j.issn.1673-4114.2012.01.007]
　LIU Yang,WANG Hui-xiang,ZHOU Tao.Application of semiquantitative analysis of whole body bone imaging on distal femoral metaphysis osseous metastasis of neuroblastoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(2):27.[doi:10.3760/cma.j.issn.1673-4114.2012.01.007]
[2]叶大铸,马寄晓.奥曲肽及其类似物用于肿瘤诊断的进展[J].国际放射医学核医学杂志,2003,27(3):97.
　YE Da-zhu,MA Ji-xiao.Advances in tumor diagnosis with labeled somatostatin analogues[J].International Journal of Radiation Medicine and Nuclear Medicine,2003,27(2):97.
[3]袁志斌.PET显像在内分泌肿瘤中的应用[J].国际放射医学核医学杂志,2003,27(5):208.
　YUAN Zhi-bin.The application of PET in endocrine tumors[J].International Journal of Radiation Medicine and Nuclear Medicine,2003,27(2):208.
[4]邵虹.神经母细胞瘤的影像学诊断[J].国际放射医学核医学杂志,2002,26(4):148.
　SHAO Hong.The imaging diagnosis of neuroblastoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2002,26(2):148.
[5]罗全勇.MIBG及其衍生物的研究进展[J].国际放射医学核医学杂志,2002,26(5):216.
　LUO Quan-yong.The recent research progress of MIBG and its derivatives[J].International Journal of Radiation Medicine and Nuclear Medicine,2002,26(2):216.
[6]傅宏亮,李佳宁,吴靖川.131I-MIBG治疗神经母细胞瘤的机制、原理和现状[J].国际放射医学核医学杂志,1999,23(6):247.

备注/Memo

备注/Memo:
收稿日期:2004-11-17。
更新日期/Last Update: 1900-01-01